This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Strom, S. S. Articles by Troncoso, P. Search for Related Content PubMed PubMed Citation Articles by Strom, S. S. Articles by Troncoso, P.

Obesity, Weight Gain, and Risk of Biochemical Failure among Prostate Cancer Patients following Prostatectomy

Authors' Affiliations: Departments of ¹ Epidemiology, ² Biostatistics, ³ Pathology, ⁴ Urology, and ⁵ Genitourinary Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Sara S. Strom, Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, 1155 Hermann Pressler Blvd., Unit 1340, Houston, TX 77030. Phone: 713-792-8274; Fax: 713-563-0999; E-mail: sstrom{at}mdanderson.org.

Purpose: Several lines of evidence suggest that diet and weight gain may be important environmental factors implicated in prostate carcinogenesis, especially in tumor progression. The purpose of this study was to evaluate obesity at different ages in a well-characterized cohort of prostate cancer patients treated with prostatectomy and to develop a prognostic model that incorporates body mass index (BMI) as a measure of obesity.

Experimental Design: We carried out a prospective study of 526 patients registered at the M.D. Anderson Cancer Center from 1992 to 2001. Kaplan-Meier and Cox proportional hazard analyses were done.

Results: During an average follow-up of 54 months, 97 (18%) post-prostatectomy patients experienced biochemical failure. Patients who were obese (BMI 30 kg/m²) at diagnosis had a higher rate of biochemical failure than nonobese men (P = 0.07). Those obese at 40 years had an even greater rate of biochemical failure (P = 0.001). Higher BMI at diagnosis [hazard ratio (HR), 1.07; P = 0.01] and Gleason score = 7(4 + 3) and 8 (HR, 3.9; P = 0.03 and HR, 10.0; P 0.001, respectively) remained significant independent predictors of biochemical failure in multivariate analysis. Men who gained weight at the greatest rate (>1.5 kg/y) between 25 years and diagnosis progressed significantly sooner (mean time, 17 months) than those who exhibited a slower weight gain (mean time, 39 months; P_trend = 0.005). The inclusion of obesity to the clinical nomogram improved performance.

Conclusions: Our findings validate the importance for a role of obesity in prostate cancer progression and suggest a link to the biological basis of prostate cancer progression that can be therapeutically exploited.

This article has been cited by other articles:

				V. Venkateswaran, A. Q. Haddad, N. E. Fleshner, R. Fan, L. M. Sugar, R. Nam, L. H. Klotz, and M. Pollak Association of Diet-Induced Hyperinsulinemia With Accelerated Growth of Prostate Cancer (LNCaP) Xenografts J Natl Cancer Inst, December 5, 2007; 99(23): 1793 - 1800. [Abstract] [Full Text] [PDF]

				S. J. Freedland and E. A. Platz Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data Epidemiol. Rev., May 3, 2007; (2007) mxm006v1. [Abstract] [Full Text] [PDF]

				D. M. Werny, T. Thompson, M. Saraiya, D. Freedman, B. J. Kottiri, R. R. German, and M. Wener Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004 Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 70 - 76. [Abstract] [Full Text] [PDF]

				C. Rodriguez, S. J. Freedland, A. Deka, E. J. Jacobs, M. L. McCullough, A. V. Patel, M. J. Thun, and E. E. Calle Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 63 - 69. [Abstract] [Full Text] [PDF]